Abstract Search

8.20 Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia

N1 Rensen , RJ Gemke , EC van Dalen , J Rotteveel , GJ Kaspers

To read the full abstract: Cochrane Database Syst Rev. 2017; 11:CD008727Glucocorticoids (GCs), such as prednisone (prednisolone) or dexamethasone, are essential agents in the treatment of acute lymphoblastic leukemia (ALL), the most common malignancy in childhood. They are administered in highly supraphysiologic doses in cyclic courses. Thus, every pediatric endocrinologist fears HPA axi...

0 shares

ey0017.6-20 | Transgender Medicine: Treatment and Cardiovascular Effects | ESPEYB17

6.20. Hormonal treatment and cardiovascular risk profile in transgender adolescents

M Klaver , R de Mutsert , M van der Loos , CM Wiepjes , JWR Twisk , M den Heijer , J Rotteveel , DT Klink

To read the full abstract: Pediatrics. 2020, Mar; 145. doi: https://pediatrics.aappublications.org/content/pediatrics/145/3/e20190741.full.pdfCardiovascular health of transgender people was a hot topic in the transgender literature last year, triggered by previous findings that these individuals could have elevated risks for cardiovascular diseases b...

0 shares

ESPE Yearbook of Paediatric Endocrinology

8.20 Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia

6.20. Hormonal treatment and cardiovascular risk profile in transgender adolescents

BiosciAbstracts